ClinicalThought

Share

Program Content

Activities

  • FAQs: BTKi in MCL
    FAQs: BTK Inhibitors in MCL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 24, 2024

Faculty

cover img faculity

Ann LaCasce, MD, MMSc

Associate Professor of Medicine
Lymphoma Program
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

John P Leonard, MD

Senior Associate Dean for Innovation and Initiatives
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Weill Cornell Medicine/NewYork-Presbyterian
New York, New York

cover img faculity

Matthew Lunning, DO, FACP

Associate Professor
Fred & Pamela Buffett Cancer Center
University of Nebraska Medical Center
Omaha, Nebraska

Provided by

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca